The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells
dc.cclicence | CC-BY-NC-ND | en |
dc.contributor.author | Lodhi, Sabahat | |
dc.contributor.author | Ankrett, Dyan N. | |
dc.contributor.author | Wilsher, Nicola E. | |
dc.contributor.author | Potter, Gerard A. | |
dc.contributor.author | Beresford, Kenneth J. M. | |
dc.contributor.author | Arroo, R. R. J. | |
dc.contributor.author | Ruparelia, K. C. | |
dc.date.acceptance | 2019-03-22 | |
dc.date.accessioned | 2019-04-02T10:16:14Z | |
dc.date.available | 2019-04-02T10:16:14Z | |
dc.date.issued | 2019-03-22 | |
dc.description | The file attached to this record is the author's final peer reviewed version. The Publisher's final version can be found by following the DOI link. | en |
dc.description.abstract | As part of a programme to develop anticancer prodrugs which are activated by cytochrome P450 (CYP)1B1, a library of 4,6-diaryl-2-pyridones was synthesised in yields of 6-60% from the corresponding chalcones. A number of these derivatives showed promising antiproliferative activities in human breast cancer cell lines which express CYP1B1 and CYP1A1, while showing little toxicity towards a non-tumour breast cell line with no CYP expression. Metabolism studies provided evidence supporting the involvement of CYP1 enzymes in the bioactivation of these compounds. | en |
dc.funder | EPSRC (Engineering and Physical Sciences Research Council) | en |
dc.identifier.citation | Ruparelia, K.C., Lodhi, S., Ankrett, D.N., Wilsher, N.E., Arroo, R.R.J., Potter, G.A., Beresford, K.J.M. (2019) The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells. Bioorganic & Medicinal Chemistry Letters, 29 (11), pp. 1403-1406 | en |
dc.identifier.doi | https://doi.org/10.1016/j.bmcl.2019.03.030 | |
dc.identifier.issn | 0960-894X | |
dc.identifier.uri | https://www.dora.dmu.ac.uk/handle/2086/17673 | |
dc.language.iso | en | en |
dc.peerreviewed | Yes | en |
dc.projectid | N/A | en |
dc.publisher | Elsevier | en |
dc.researchinstitute | Leicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI) | en |
dc.subject | 4,6-diaryl-2-pyridones | en |
dc.subject | chalcones | en |
dc.subject | antiproliferative | en |
dc.subject | prodrug | en |
dc.subject | CYP1B1 | en |
dc.title | The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells | en |
dc.type | Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ruparelia-BioorgMedChemLett-2019.pdf
- Size:
- 359.13 KB
- Format:
- Adobe Portable Document Format
- Description:
- PDF of author's post-print copy (i.e. final draft post-refereeing)
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 4.2 KB
- Format:
- Item-specific license agreed upon to submission
- Description: